Research map: Le diagnostic sanguin de la maladie d’Alzheimer : utopie ou dystopie ?

Back to the article

Papers in this map

  1. Clinical diagnosis of Alzheimer's disease · Guy M. McKhann · 1984 · 28087 citations · Cited by this paper
  2. Protoxyde d’azote et addictovigilance : du signal au problème de santé publique · 2026 · Related
  3. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup · Clifford R. Jack · 2024 · 2682 citations · Cited by this paper
  4. Que peut-on attendre du médecin de demain ? Permanence de l’art de soigner à l’ère de l’innovation · 2026 · Related
  5. High performance plasma amyloid-β biomarkers for Alzheimer’s disease · Akinori Nakamura · 2018 · 1741 citations · Cited by this paper
  6. Communiqué. Médecine esthétique : un enjeu de santé publique nécessitant un encadrement renforcé · 2026 · Related
  7. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia · Willemijn J. Jansen · 2015 · 1663 citations · Cited by this paper
  8. Discussion à propos de la communication : « Épidémiologie de l’infertilité en France et dans le monde » · 2026 · Related
  9. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders · Sebastian Palmqvist · 2020 · 1662 citations · Cited by this paper
  10. Homo Addictus : approche anthropologique des addictions · 2026 · Related
  11. Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 · Thomas G. Beach · 2012 · 1124 citations · Cited by this paper
  12. Discussion à propos de la communication: « Nouvelle classification phénotypique des malformations vasculaires périphériques: actualisation ISSVA 2025 » · 2026 · Related
  13. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group · Bruno Dubois · 2021 · 1070 citations · Cited by this paper
  14. Nouveaux horizons dans la recherche sur la fibrose pulmonaire idiopathique : du dysfonctionnement épithélial à la polarisation dérégulée des macrophages et à la fibrogenèse · 2026 · Related
  15. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology · Nicholas James Ashton · 2024 · 883 citations · Cited by this paper
  16. Sommaire · 2026 · Related
  17. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated · John L. Robinson · 2018 · 763 citations · Cited by this paper
  18. Syndrome de Turner : une pathologie génétique de la croissance, au-delà d’un déficit en hormone de croissance. Du retard statural au dépistage précoce · 2026 · Related
  19. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia · Gil D. Rabinovici · 2019 · 690 citations · Cited by this paper
  20. Defining Alzheimer’s disease: stipulations and the ethics of diagnostic change · 2026 · Related
  21. Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation · Bruno Dubois · 2024 · 407 citations · Cited by this paper
  22. Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility · Thomas K. Karikari · 2022 · 354 citations · Cited by this paper
  23. Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease · Suzanne Elizabeth Schindler · 2024 · 298 citations · Cited by this paper
  24. A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases · Wagner Scheeren Brum · 2023 · 259 citations · Cited by this paper
  25. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads · Gemma Salvadó · 2023 · 213 citations · Cited by this paper
  26. Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia · David A. Bergeron · 2018 · 207 citations · Cited by this paper
  27. Head‐to‐head comparison of leading blood tests for Alzheimer's disease pathology · Suzanne Elizabeth Schindler · 2024 · 184 citations · Cited by this paper
  28. Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease · Ron Brookmeyer · 2018 · 178 citations · Cited by this paper
  29. Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease · Kanta Horie · 2025 · 122 citations · Cited by this paper
  30. Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability · Joseph Therriault · 2024 · 110 citations · Cited by this paper
  31. Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis · Joseph Therriault · 2025 · 89 citations · Cited by this paper
  32. Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis · Samir Abu‐Rumeileh · 2025 · 75 citations · Cited by this paper
  33. Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics · Nicolas Villain · 2025 · 74 citations · Cited by this paper
  34. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis · Marianne Chapleau · 2024 · 73 citations · Cited by this paper
  35. Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platform · Azadeh Feizpour · 2024 · 73 citations · Cited by this paper
  36. Plasma p-tau217 in Alzheimer’s disease: Lumipulse and ALZpath SIMOA head-to-head comparison · Andrea Pilotto · 2024 · 63 citations · Cited by this paper
  37. Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk · Clifford R. Jack · 2022 · 57 citations · Cited by this paper
  38. Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment · Sylvain Lehmann · 2024 · 57 citations · Cited by this paper
  39. Added value of 18 F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study · Mathieu Pierre Ceccaldi · 2017 · 56 citations · Cited by this paper

Source: OpenAlex (CC0)